Combined treatment of multiple sclerosis

US6060501A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Helmut Wachtel · Berlin, DE
• Peter-Andreas Loschmann · Berlin, DE
• Hermann Graf · Berlin, DE
• H. Perez · Poway, US

Key dates

• Filing date: Sep 24, 1997
• Grant date: May 9, 2000
• Expiry date: Sep 24, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutically composition for treating MS comprising an effective amount of a combination of a PDE IV inhibitor and an anti-inflammatory and immunomodulatory drug in a pharmaceutically acceptable carrier.